Upgrade to SI Premium - Free Trial

Unusual 11 Mid-Day Movers 6/13: (EBIO) (LNKD) (PWE) Higher; (MRNS) (GBR) (ARGS) Lower

June 13, 2016 1:01 PM
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) 69.6% LOWER; announced top-line results from its Phase 3 clinical trial in adults with drug-resistant ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles